MHRA-100239-PIP01-21-M01 (update)

Key Facts

Active Substance
Active Substance:
  • Multivalent pneumococcal polysaccharide conjugate to carrier protein
Invented Name
Not available at present
PIP Number MHRA-100239-PIP01-21-M01 (update)
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Suspension for injection in pre-filled syringe
Therapeutic area
Therapeutic area:
  • Vaccines
Conditions / Indications
Conditions / Indications:
  • Prevention of disease caused by Streptococcus pneumoniae
Route(s) of administration
Route(s) of administration:
  • Intramuscular use
PIP applicant
Decision Type
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Multivalent pneumococcal polysaccharide conjugate to carrier protein.pdf
Published Date 03/10/2024